About Avenue Biosciences Holding
Avenue Biosciences Holding is a private company based in Menlo Park, California, incorporated in 2023 in Delaware. It has reported $7,440,682 raised in one offering on Form D since January 2026. Its chief executive is Tero-Pekka Alastalo.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 20, 2025 | Jan 28, 2026 | $7,440,682of $8.3M target | 12 | $620K | EquityRule 506(c) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Avenue Biosciences Holding's Form D filed Jan 28, 2026.
JE
Jenny Engerfelt
Director
GP
Gabriel Poteliunaite
Director
KR
Katja Rosti
Executive officer and director
TA
Tero-Pekka Alastalo
CEO and director